Therapies Invest Information

Stocks
Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Receives $6.63 Average Price Target from Analysts Mar 14, 2025
Companies
CytoMed Therapeutics Offers Free Cell Banking to Eligible Shareholders for Future Precision Medicine Mar 18, 2024
Finance
Aeglea BioTherapeutics AGLE Receives Sell Rating Amid Market Dynamics Nov 13, 2023
Stocks
StockNews.com Issues a Sell Rating for Minerva Neurosciences Amid Institutional Trading Activity Nov 12, 2023